GlaxoSmithKline Said to Settle U.S. False Claims Lawsuit for $750 Million

GlaxoSmithKline Plc settled a U.S. government lawsuit under the False Claims Act for $750 million, according to a person familiar with the matter.

To contact the reporter on this story: Justin Blum in Washington at jblum4@bloomberg.net

To contact the editor responsible for this story: David Rovella at drovella@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.